LEXINGTON, Mass., Feb. 17, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the Citi 2012 Global Healthcare Conference at 4:00 p.m. EST on February 27, 2012, in New York City.
